On January 4, 2021 Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) ("Innate" or the "Company") reported that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences (Press release, Innate Pharma, JAN 4, 2021, View Source [SID1234573382]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
ODDO BHF Digital Forum
Date: January 7-11, 2021
SternIR Virtual Corporate Access Event
Date: January 11-14, 2021
Presentation: A pre-recorded presentation will be available for on-demand viewing in the Investors section of the Innate Pharma website, www.innate-pharma.com, beginning Monday, January 11, 2021.